Editorial for “Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form”-Reference-Cited by-同舟云学术

Editorial for “Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form”

Published:2023-01-20 Issue:2 Volume:12 Page:167
ISSN:2076-0817
Container-title:Pathogens
language:en
Short-container-title:Pathogens

Author:

Dotan Arad¹²,Shoenfeld Yehuda¹²

Affiliation:

1. Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat Gan 5265601, Israel

2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel

Abstract

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first reported in December 2019, has infected numerous subjects worldwide [...]

Publisher

MDPI AG

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy

Link

https://www.mdpi.com/2076-0817/12/2/167/pdf

Reference23 articles.

1. Post-COVID syndrome: The aftershock of SARS-CoV-2;Dotan;Int. J. Infect. Dis.,2022

2. Shoenfeld, Y., and Dotan, A. (2022). Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination, Elsevier.

3. A review of persistent Post-COVID syndrome (PPCS);Oronsky;Clin. Rev. Allergy Immunol.,2021

4. (2022, December 27). Long COVID or Post-COVID Conditions|CDC, Available online: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.

5. Amenta, E.M., Spallone, A., Rodriguez-Barradas, M.C., Sahly, H.M.E., Atmar, R.L., and Kulkarni, P.A. (2020). Open Forum Infectious Diseases, Oxford University Press.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ivermectin as a Potential Addition to the Limited Anti-COVID-19 Arsenal: A Double-Blinded Clinical Trial;Jundishapur Journal of Health Sciences;2024-04-30